FluoGuide A/S (OMXSTO:FLUO) Financings
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Private placement of shares Closed: SEK 104M raised · SEK 38 a share · Navia Corporate Finance AB +4 Dealers: Navia Corporate Finance AB (co-lead), Redeye AB (co-lead), Translution Capital (co-lead), Navia Corporate Finance (co-lead), Redeye (co-lead) Buyers: Several of the Company's major and institutional shareholders (expressed interest in participating with approximately SEK 95 million) Use of proceeds: Phase II trials of FG001 in HGG in the US and in head and neck cancer, CMC and drug manufacturing for phase III HGG trial, and general corporate purposes | Nov 3, 2025 | US$10.96M |